News Archives - neurocare clinics Australia

Enquire Online TodayWe are here to help 1300 149 300Speak with our friendly team

1 January 2022

Recently the Australian Federal Government announced in the budget significant funding towards mental health initiatives, including $288.9m to approve and MBS item for the highly effective antidepressant treatment repetitive Transcranial Magnetic Stimulation (rTMS).

neurocare group

23 March 2020

neurocare group

21 July 2019

Medical Practitioners, Researchers and Mental Health Professionals in Melbourne are invited to join a Q&A session in August with Dr Martijn Arns, leading researcher in the areas of TMS in Depression, OCD and Neurofeedback in ADHD and Sleep Disorders.

The Conversation

26 September 2018

A study at the University of Southern California has investigated the link between digital media use and the development of ADHD-related behaviours among 15- and 16-year-olds. This study highlights a potential association between digital media and behavioural symptoms typically associated with ADHD.

neurocare group

1 July 2018

New study shows brain activity measured by QEEG can help predict which children may or may not respond to medications for ADHD

neurocare group

19 February 2018

Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication free technique, has long-lasting effects, according to a recent study published in the medical journal European Child & Adolescent Psychiatry.

neurocare group

6 February 2018

Researchers find cost of rTMS treatment to be more cost-effective as compared to antidepressant medication trials, factoring in financial commitment and quality of life post treatment.

neurocare group

15 November 2017

New study shows that magnetic brain stimulation (TMS) combined with concurrent psychotherapy is more effective than either technique alone with 66% of research subjects with Depression responding well in an average of 21 session. 65% of the group achieved long-term benefit.

neurocare group

26 October 2017

Members of the Royal Australian and New Zealand College of Psychiatry are putting forward a new submission to have TMS subsidized under Australia’s public health fund, Medicare.

neurocare group

21 September 2017

neuroCare’s brand of evidence-based and sustainable therapies for ADHD, Depression & OCD, is now available in Melbourne as the company joins with the Listen And Learn Centre in Balwyn.

Older Posts

We integrate leading research, digital therapeutics, physical devices, clinics, and professional education to offer the most comprehensive mental health solutions to patients, therapists and the research community.

Visit our global website
www.neurocaregroup.com

neuroCademy Professional Training & Science
www.neurocademy.com

SPA Member Logo

Australians with Treatment-Resistant Depression can now benefit from Medicare funding for TMS therapy

A Message To Our Clients Regarding Coronavirus

Dr Martijn Arns visits Melbourne for talk series “Neuromodulation in Australia: New Approaches in Mental Healthcare”

Research Check: are phone-obsessed teens at greater risk of ADHD?

Brain activity predicts response to medication in ADHD

New Study Confirms Neurofeedback has long-term benefit for Children with ADHD

TMS more cost-effective treatment for major depressive disorder, study finds

Combined TMS and Psychotherapy more effective treatment for Depression

Australian Psychiatrists push for TMS to be subsidised

neuroCare opens new clinic in Melbourne, joining with Listen And Learn centre